CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition Director disposed of 414,816 shares (other)
- 4 Open-market sale Director sold 3,035 shares at $86.87 ($263,636)
- 4 Open-market sale Director sold 8,965 shares at $86.98 ($779,777)
- 4 Open-market sale Director sold 1,155 shares at $84.89 ($98,045)
- 4 Open-market sale Director sold 22,845 shares at an average $85.36 ($1,949,996)
- 4 Open-market sale Director sold 60,000 shares at an average $92.51 ($5,550,644)
- 4 Open-market sale Chief Financial Officer sold 12,000 shares at an average $92.26 ($1,107,068)
- 4 Open-market sale President sold 25,000 shares at an average $92.62 ($2,315,578)
- 4 Shares withheld for taxes Chief Executive Officer gave up 779 shares (to pay taxes)
- 4 Open-market sale President sold 25,000 shares at $100.00 ($2,500,000)
- 4 Other acquisition Director acquired 71 shares (other)
- 4 Open-market sale Chief Financial Officer sold 12,000 shares at an average $86.74 ($1,040,919)
- 4 Open-market sale President sold 25,000 shares at $90.00 ($2,250,000)
- 4 Open-market sale Director sold 20,000 shares at an average $82.39 ($1,647,730)
- 4 Open-market sale President sold 50,000 shares at $80.00 ($4,000,000)
- 4 Open-market sale CBO & COO sold 70,000 shares at an average $75.88 ($5,311,564)
- 4 Open-market sale President sold 50,000 shares at $75.00 ($3,750,000)
- 4 Open-market sale Director sold 20,000 shares at an average $73.93 ($1,478,522)
Page 14 of 26 · 502 filings